Issue 4/2009
Content (17 Articles)
From standardization to personalization in breast cancer treatment
Shinzaburo Noguchi, Masakazu Toi
Breast cancer risk assessment for possible tailored screening for Japanese women
Yasuhiro Tamaki, Yasuyuki Kotsuma, Yasuo Miyoshi, Shinzaburo Noguchi
Triple negative breast cancer: clinicopathological characteristics and treatment strategies
Futoshi Akiyama, Hirotaka Iwase
Clinicopathological characteristics of triple-negative breast cancers
Yuka Sasaki, Hitoshi Tsuda
Clinical significance of basal-like subtype in triple-negative breast cancer
Yutaka Yamamoto, Mutsuko Ibusuki, Masahiro Nakano, Teru Kawasoe, Ryousuke Hiki, Hirotaka Iwase
Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction
Tomohiko Ohta, Wenwen Wu, Ayaka Koike, Hideki Asakawa, Hirotaka Koizumi, Mamoru Fukuda
Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics
Junichi Kurebayashi
Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer
Goi Sakamoto, Naoko Honma
Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer
Masafumi Kurosumi
Recent trends of HER-2 testing and trastuzumab therapy for breast cancer
Masafumi Kurosumi
The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review
Yutaka Tokuda, Yasuhiro Suzuki, Yuki Saito, Shinobu Umemura
Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
Masahiko Tanabe, Yoshinori Ito, Nahomi Tokudome, Tsutomu Sugihara, Hiroyoshi Miura, Shunji Takahashi, Yasuyuki Seto, Takuji Iwase, Kiyohiko Hatake
A cluster of microcalcifications: women with high risk for breast cancer versus other women
Takayoshi Uematsu, Masako Kasami, Sachiko Yuen